BIO-TECHNE Corp (TECH) Financials
Annual revenue, profitability and per-share results for BIO-TECHNE Corp, as reported in SEC filings.
Revenue · FY2026
$1.22B
▼ 0.4%YoY
Net income · FY2026
$181.86M
▲ 147.8%YoY
Gross margin · FY2026
65.8%
Diluted EPS · FY2026
$1.16
▲ 152.2%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2026 | $1.22B | $181.86M | $799.07M | $1.16 | $263.22M | 20.7% | -0.4% |
| FY2025 | $1.22B | $73.40M | $790.27M | $0.46 | $256.55M | 8.4% | +5.2% |
| FY2024 | $1.16B | $168.10M | $769.73M | $1.05 | $236.10M | 17.8% | +2.0% |
| FY2023 | $1.14B | $285.44M | $769.82M | $1.76 | $216.15M | 26.3% | +2.8% |
Figures as reported in BIO-TECHNE Corp's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a TECH filing.
Get an email when TECH files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.